PharmExec

Pharmaceutical Executive Daily: FDA Approves Pasatru

A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves ...
PharmExec

M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration

UroGen Pharma has invested in IntraGel Therapeutics and secured an exclusive option to license Tumocure, and Lupin's ...
PharmExec

The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi

Pharmaceutical reshoring is constrained by supplier qualification, process validation, FDA compliance readiness, workforce ...
PharmExec

FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva

FDA approval in adult FOP targets disease-driving Activin A biology, addressing progressive heterotopic ossification that ...
PharmExec

What Are the Specific Metrics to Look for Following the Tariff Announcement?

Rohit Tripathi, VP of Industry Strategy at RELEX, lays out the five signals that he believes can measure if the tariff policy ...
PharmExec

President Trump Set to Nominate Heidi Overton as FDA Commissioner

President Trump has reportedly selected White House Domestic Policy Council deputy director Heidi Overton as his nominee for ...
PharmExec

When Drug Pricing Becomes Trade Policy

How drug pricing, tariffs, and manufacturing decisions are becoming connected. For years, pharmaceutical companies could ...
PharmExec

Pharmaceutical Executive Daily: President Trump to Nominate Heidi Overton as FDA Commissioner

Heidi Overton, a UNM-trained physician with Johns Hopkins general surgery training, was selected for FDA commissioner after ...
PharmExec

From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle

Most pharma companies have promising AI pilots. Few have built the conditions to scale them. Here's what separates the ...
PharmExec

What Does the Operational Reality of Reshoring Actually Look Like?

Rohit Tripathi, VP of Industry Strategy at RELEX, discusses how pharmaceutical reshoring demands end-to-end capability not ...
PharmExec

Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026

Pharmaceutical Executive releases its 2026 Top 50 company rankings, FDA grants Bristol Myers Squibb's Zenbexus accelerated ...
Pharm Exec

2026 Pharm Exec Top 50 Companies

A changing of the guard atop Pharm Exec’s latest listing of the top biopharma Rx revenue producers reflects an industry being remade in real time, becoming as much a map of franchise quality and ...